Treatment drug for corona has arrived, with a price...
By John Kubisk
@JohnKu (2552)
July 1, 2020 5:48am CST
Gilead, California-based pharmaceutical company has announced the price for their approved antiviral drug for coronavirus a few days ago. Remdesivir, the name of the drug will be sold for $390 per dose for wealthy countries, while less fortunate countries will be able to buy the drug for a lower price.
Considering the current global condition and the dire needs for corona treatment, I think it would be wise to make the drug more accessible and possibly free for all. What do you think about this?
12 people like this
9 responses
@m_audrey6788 (58485)
• Germany
1 Jul 20
We are still not sure how effective it is because why corona still rising in their place?
2 people like this
@m_audrey6788 (58485)
• Germany
1 Jul 20
@myklj999 Oh ok. Is it really effective?
1 person likes this
@m_audrey6788 (58485)
• Germany
1 Jul 20
@JohnKu I hope it will help a lot of people with the virus
1 person likes this
@Lavanya15 (12888)
• Chennai, India
1 Jul 20
I also read news about it. For next three months production completely go for America. Because America already placed order.
2 people like this
@Lavanya15 (12888)
• Chennai, India
1 Jul 20
@JohnKu yes my friend. But don't know how much success they get.
1 person likes this
@Letranknight2015 (51532)
• Philippines
1 Jul 20
Expensive, eh? This is why I rather avoid getting the covid than expecting a vaccine.
1 person likes this
@JohnKu (2552)
•
1 Jul 20
Sadly, looking at how fast the virus can spread all over the world I'm not sure if we can continually avoid it.
@JohnKu (2552)
•
1 Jul 20
Sadly true. Oh well at least we got something, it's better than nothing at all.
@JohnKu (2552)
•
1 Jul 20
Agree. I don't even dare to imagine just how much a corona vaccine will cost us in the future.
@just4him (306356)
• Green Bay, Wisconsin
1 Jul 20
I saw it on the news a couple of days ago and thought they were making it impossible to use the vaccine. Considering the pandemic, it should be accessible to everyone.